We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Aragen Bioscience, a fully owned subsidiary of GVK BIO and a large molecule CRO, and University of Technology Sydney (UTS), a university in Australia, have formed a collaboration to accelerate biologics R&D in Australia.
GVK BIO Announces the Promotion of Sudhir Kumar Singh to Chief Operating Officer and Appointment of Ramesh Subramanian as the New Chief Commercial Officer of GVK BIO
BIO announced the launch of India’s first mobile App ‘eCule’ for drug discovery services. The App simplifies the whole ordering process from inquiry to delivery and also allows live tracking to stay apprised with the project.